Ng Kee Kwong, Koy ChongHarbham, Pratap K.Selvaraj, Bhuvaneish T.Gregory, JennaPal, SuvankarHardingham, Giles E.Chandran, SiddharthanMehta, Arpan R.2022-07-062022-07-062021-03-18Ng Kee Kwong, K C, Harbham, P K, Selvaraj, B T, Gregory, J, Pal, S, Hardingham, G E, Chandran, S & Mehta, A R 2021, '40 Years of CSF Toxicity Studies in ALS : What Have We Learnt About ALS Pathophysiology?', Frontiers in Molecular Neuroscience, vol. 14, 647895. https://doi.org/10.3389/fnmol.2021.6478951662-5099ORCID: /0000-0003-3337-4079/work/112144115https://hdl.handle.net/2164/18803AM is a Lady Edith Wolfson Clinical Fellow and is jointly funded by the Medical Research Council (MRC) and the Motor Neurone Disease Association (MR/R001162/1). He also acknowledges support from the Rowling Scholars scheme, administered by the Anne Rowling Regenerative Neurology Clinic (ARRNC), University of Edinburgh, and a seedcorn grant from The Chief Scientist Office and the RS Macdonald Charitable Trust via the Scottish Neurological Research Fund, administered by the University of St Andrews. The Hardingham and Chandran laboratories are supported by the Euan MacDonald Centre for Motor Neurone Disease Research, and the UK Dementia Research Institute (DRI), which receives its funding from UK DRI Ltd., funded by the MRC, Alzheimer’s Society and Alzheimer’s Research UK.112118146engamyotrophic lateral sclerosis, cerebrospinal fluidmotor neuron diseaseneurodegenerationpathophysiologytoxicityRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryMedical Research Council (MRC)MR/R001162/1Alzheimers Research UKRC0321Journal article10.3389/fnmol.2021.647895http://dx.doi.org/10.3389/fnmol.2021.64789514